616 692
[11]
HadjipavlouM, Khan F, Fowler S, et al. Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int 2016;117:62–71.
[12]
Meskawi M, Becker A, Bianchi M, et al. Partial and radical nephrec- tomy provide comparable long-term cancer control for T1b renal cell carcinoma. Int J Urol 2014;21:122–8.[13]
Hansen J, Sun M, Bianchi M, et al. Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 2012;80:347–53.
[14]
Kopp RP, Mehrazin R, Palazzi KL, et al. Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int 2014;114:708–18.[15]
Long CJ, Canter DJ, Kutikov A, et al. Partial nephrectomy for renal masses 7 cm: technical, oncological and functional outcomes. BJU Int 2012;109:1450–6.
[16]
Maddox M, Mandava S, Liu J, Boonjindasup A, Lee BR. Robotic partial nephrectomy for clinical stage T1b tumors: intermediate oncologic and functional outcomes. Clin Genitourin Cancer 2015;13:94–9.
[17]
Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H. Outcome of nephron-sparing surgery for T1b renal cell carcinoma. BJU Int 2009;103:1344–8.
[18]
Becker F, Roos FC, Janssen M, et al. Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours 7 c m. Eur Urol 2011;59:931–7.
[19]
Bigot P, He´tet JF, Bernhard JC, et al. Nephron-sparing surgery for renal tumors measuring more than 7 c m: morbidity, and functional and oncological outcomes. Clin Genitourin Cancer 2014;12:e19–27.[20]
Kim SP, Thompson RH, Boorjian SA, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188:51–7.[21]
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
[22]
Roos FC, Brenner W, Mu¨ ller M, et al. Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohort. Urology 2011;77:803–8.[23]
Roos FC, Brenner W, Thomas C, et al. Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 2012;79:607–13.
[24]
Kopp RP, Liss MA, Mehrazin R, et al. Analysis of renal functional outcomes after radical or partial nephrectomy for renal masses 7 c m Using the RENAL score. Urology 2015;86:312–9.[25]
Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multi- center experience. J Urol 2004;171:2181–5.
[26]
Dash A, Vickers AJ, Schachter LR, Bach AM, Snyder ME, Russo P. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4-7 cm. BJU Int 2006;97: 939–45.
[27]
Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 2006;67:260–4.
[28]
Simmons MN, Weight CJ, Gill IS. Laparoscopic radical versus partial nephrectomy for tumors > 4 cm: intermediate-term oncologic and functional outcomes. Urology 2009;73:1077–82.
[29]
Antonelli A, Cozzoli A, Nicolai M, et al. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol 2008;53:803–9.[30]
Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 2009;182:2601–6.
[31]
Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010;183:1317–23.[32]
Deklaj T, Lifshitz DA, Shikanov SA, Katz MH, Zorn KC, Shalhav AL. Laparoscopic radical versus laparoscopic partial nephrectomy for clinical T1bN0M0 renal tumors: comparison of perioperative, pathological, and functional outcomes. J Endourol 2010;24: 1603–7.
[33]
Kim JM, Song PH, KimHT, Park TC. Comparison of partial and radical nephrectomy for pT1b renal cell carcinoma. Korean J Urol 2010; 51:596–600.
[34]
Weight CJ, Larson BT, Gao T, et al. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology 2010;76:631–7.
[35]
Antonelli A, Ficarra V, Bertini R, et al. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi- institutional study. BJU Int 2012;109:1013–8.
[36]
Iizuka J, Kondo T, Hashimoto Y, Kobayashi H, et al. Similar func- tional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma. Int J Urol 2012;19:980–6.
[37]
Brewer K, O’Malley RL, Hayn M, et al. Perioperative and renal function outcomes of minimally invasive partial nephrectomy for T1b and T2a kidney tumors. J Endourol 2012;26:244–8.
[38]
Milonas D, Skulcˇius G, Baltrimavicˇius R, et al. Comparison of long- term results after nephron-sparing surgery and radical nephrec- tomy in treating 4- to 7-cm renal cell carcinoma Medicina (Kaunas) 2013;49:223–8.
[39]
Pignot G, Bigot P, Bernhard JC, et al. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function ben- efit even when expanding indications beyond the traditional 4-cm cutoff. Urol Oncol 2014;32:1024–30.
[40]
Jang HA, Kim JW, Byun SS, et al. Oncologic and Functional outcomes after partial nephrectomy versus radical nephrectomy in T1b renal cell carcinoma: a multicenter, matched case-control study in Ko- rean patients. Cancer Res Treat 2016;48:612–20.[41]
Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007;100:1235–9.
[42]
Jeldres C, Patard JJ, Capitanio U, et al. Partial versus radical nephrec- tomy in patients with adverse clinical or pathologic characteristics. Urology 2009;73:1300–5.
[43]
Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 2010;183:903–8.[44]
Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncol- ogic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011; 59:543–52.
[45]
Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010;210:901–8.
[46]
Klatte T, Ficarra V, Gratzke C, et al. A literature review of renal surgical anatomy and surgical strategies for partial nephrectomy. Eur Urol 2015;68:980–92.
[47]
Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective random- ized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51:1606–15.
[48]
Lane BR, Demirjian S, Derweesh IH, Riedinger CB, Fergany AF, Campbell SC. Is all chronic kidney disease created equal? Curr Opin Urol 2014;24:127–34.
E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 6 0 6 – 6 1 7
616